Abstract

Background When a new drug becomes available, patients and doctors require information on its benefits and harms. In 2011, Germany introduced the early benefit assessment of new drugs through the...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Low Backache
P H Kendall
BMJ | VOL. 1
P H KendallP H Kendall
29 Jan 1955
Completeness of Reporting of Patient-Relevant Clinical Trial Outcomes: Comparison of Unpublished Clinical Study Reports with Publicly Available Data
Marloes Kamphuis ... Ulrich Grouven
PLoS Medicine | VOL. 10
Marloes Kamphuis, et. al.Marloes Kamphuis ... Ulrich Grouven
08 Oct 2013
Comparison of consistency and complementarity of reporting biosimilar quality attributes between regulatory and scientific communities: An adalimumab case study
Helga Gardarsdottir ... Toine C Egberts
Biologicals | VOL. 69
Helga Gardarsdottir, et. al.Helga Gardarsdottir ... Toine C Egberts
01 Jan 2020
Information for Adequate Prescribing to Older Patients
Hubert G M Leufkens ... Erna Beers
Drugs & Aging | VOL. 30
Hubert G M Leufkens, et. al.Hubert G M Leufkens ... Erna Beers
19 Feb 2013
View more papers

More From: BMJ : British Medical Journal

Paper Title
Journal
Date
Author
Diagnosis and management of menopause: summary of NICE guidance
M A Lumsden ... M Davies
BMJ : British Medical Journal | VOL. 351
M A Lumsden, et. al.M A Lumsden ... M Davies
12 Nov 2015
University of Toronto researcher resigns over “systematic” data fraud
O Dyer
BMJ : British Medical Journal | VOL. 351
O DyerO Dyer
12 Nov 2015
Pelvic pain
R Brown ... S Vyas
BMJ : British Medical Journal | VOL. 351
R Brown, et. al.R Brown ... S Vyas
12 Nov 2015
Amblyopia
A J Connor ... J M Jefferis
BMJ : British Medical Journal | VOL. 351
A J Connor, et. al.A J Connor ... J M Jefferis
12 Nov 2015
View more papers